Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Ultrasound Examination and Guided Injection Into the Acromio-clavicular Joint

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2012 by gordon edelson, The Baruch Padeh Medical Center, Poriya.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
gordon edelson, The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier:
NCT01628796
First received: June 19, 2012
Last updated: June 26, 2012
Last verified: June 2012
  Purpose
Is it possible to improve the accuracy of injection into the acromio-clavicular joint with the use of ultrasound?

Condition Intervention
Osteoarthritis of Acromioclavicular Joint
Other: contrast material injection

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Ultrasound Measurement of the Acromio-clavicular Joint and Injection of Standard Contrast Material Into the Joint Under Ultrasonic Control

Resource links provided by NLM:


Further study details as provided by gordon edelson, The Baruch Padeh Medical Center, Poriya:

Primary Outcome Measures:
  • ultrasound controlled injection of contrast material into the AC joint followed by standard x-ray [ Time Frame: outcome assessed at the time of the injection (1 day) ]
    standard x-ray will be taken after the contrast dye has been injected into the joint to see whether it has successfully been placed into the joint.


Estimated Enrollment: 30
Study Start Date: July 2012
Estimated Study Completion Date: January 2013
Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: contrast material injection
    using ultrasound to locate ac joint and injecting contrast material to ensure that the dye is actually in the joint
    Other Name: iomeron 350
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • adults over 18 years with AC joint degenerative changes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01628796

Contacts
Contact: Gordon Edelson, MD 97246652670 edelson@bezeqint.net

Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
  More Information

Responsible Party: gordon edelson, Professor of Orthopedic Surgery, The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier: NCT01628796     History of Changes
Other Study ID Numbers: 08-2012.CTIL
Study First Received: June 19, 2012
Last Updated: June 26, 2012

Additional relevant MeSH terms:
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on May 25, 2017